Strata Oncology will present new data on its innovative, proprietary biomarkers at #NACLC23 and #SABCS23
Read more: bit.ly/3R236D7
#lungcancer #NSCLC #breastcancer #biomarkers #immunotherapy #AntibodyDrugConjugates
Strata is honored to be this year's "Diagnostics Innovation of the Year" award by @BioTech_Awards! This award is in recognition of Strata Select, our first-of-its-kind pan-solid tumor molecular profiling solution for patients with advanced cancer. Learn more: bit.ly/3SARJ7B
Strata CEO Dan Rhodes sat down with @CLPmag to discuss the promise and challenges facing precision oncology
clpmag.com/diagnostic-techno…
We’re thrilled to announce that Goz Alhir has joined Strata Oncology as SVP, Commercialization. He brings a wealth of experience and an unrelenting dedication to improving patients' lives to the team.
Read more:bit.ly/3M0d4DB
Congrats to Scott Tomlins on being a 2023 @PharmaVOICE 100 honoree! Thank you for your endless commitment to improving the lives of patients with cancer. View his profile here: bit.ly/3PIvZES
3
176
In Boston for @LSXLeaders USA Congress? Catch Strata Oncology Chief Business Development, Legal and Compliance Officer Catherine Sazdanoff on the "Future of Oncology Pharmaceutical Partnerships" panel with speakers from @GSK, @AstellasUS and @ServierPharma
2
144
Strata Oncology is excited to announce new data supporting the utility of the Immunotherapy Response Score to guide informed clinical decisions for first-line treatment of patients with #NSCLC, to be presented at #WCLC23, hosted by @IASLC bit.ly/3EuOoyC
Read about how the Immunotherapy Response Score can help guide critical immunotherapy decisions for patients with advanced cancer in a recent article by our co-founder and Chief Medical Officer Scott Tomlins
linkedin.com/pulse/immunothe…
101
Strata Oncology is excited to announce the publication of a new study adding to the clinical utility of our innovative Immunotherapy Response Score, which is available as part of the Strata Select molecular profiling test.
Read the latest results in @CRC_AACR!
Just published—
Validation of Immunotherapy Response Score as predictive of pan-solid tumor anti-PD-1/PD-L1 benefit, by Bulen et al.
bit.ly/448xMYV
@StrataOncology #openaccess
4
230
Dr. Sachdev Thomas of Kaiser Permanente spoke with @OncLive about the independent validation of Strata's #Immunotherapy Response Score that his team conducted
onclive.com/view/dr-thomas-o…
Another year, another @ASCO meeting, another amazing opportunity to connect with the #PrecisionOncology community to bond over our shared goal of ensuring every patient with cancer gets their best possible therapy
See you next year! Goodbye #ASCO23!
3
195
Strata Select helps you make a critical treatment decision for your patients with advanced cancer – whether or not to treat with anti-PD-1/PD-L1 #immunotherapy and, if so, whether to prescribe monotherapy or combination therapy
Learn more at #ASCO23 booth #24081
#PrecisionOncology
At #ASCO23?
Be sure to visit Strata Oncology at booth ##24081 to learn more about Strata Select, a pan-solid tumor molecular profiling test for patients with advanced cancer that provides treatment selection guidance for #immunotherapy and beyond
#PrecisionOncology #Biomarkers
2
185
We’re excited to be in Chicago for #ASCO23! Be sure to stop by booth #24081 to talk with our team about #PrecisionOncology, #Immunotherapy and the recently launched Strata Select test
Connect with us this weekend at #ASCO23 to learn more about Strata Select, including new data just published in an ASCO abstract -- an independent validation of the Immunotherapy Response Score conducted by Kaiser Permanente.
meetings.asco.org/abstracts-…
2
146
We're proud to be on the list for @FastCompany's World Changing Ideas Awards for the second year in a row, this time for the Immunotherapy Response Score!
Learn more: https://teapaw.org/t.co/Sdsq4FkAH9
#FCWorldChangingIdeas
1
141
Announcing Strata Select, a first-of-its-kind molecular profiling for patients with advanced cancer. This marks a significant milestone in our pursuit to deliver precision immunotherapy and empower oncologists to make better-informed treatment decisions. https://teapaw.org/t.co/EruopA5beu
If you're at #AACR23, be sure to check out our posters! Abstract numbers and links in press release linked below. Have a great meeting!
Strata Oncology will present new data in four scientific posters at the upcoming American Association for Cancer Research Annual Meeting #AACR23
Read more: https://teapaw.org/t.co/qqJiE73Qur
162
CMO Scott Tomlins sat down with @Inside_PM to discuss why researchers are focused on biomarker discovery to unlock the potential of immunotherapy - a trend he notes will "pave the way toward giving more patients the hope of an actual cure."
More here: insideprecisionmedicine.com/…
Strata Oncology will present new data in four scientific posters at the upcoming American Association for Cancer Research Annual Meeting #AACR23
Read more: https://teapaw.org/t.co/qqJiE73Qur














